Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $128.3 million.

  • Healthequity's Free Cash Flow rose 6449.43% to $128.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $364.9 million, marking a year-over-year increase of 2473.21%. This contributed to the annual value of $288.7 million for FY2025, which is 4314.46% up from last year.
  • As of Q4 2025, Healthequity's Free Cash Flow stood at $128.3 million, which was up 6449.43% from $125.5 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Free Cash Flow ranged from a high of $128.3 million in Q4 2025 and a low of -$6.6 million during Q2 2022
  • Moreover, its 5-year median value for Free Cash Flow was $46.1 million (2021), whereas its average is $51.2 million.
  • The largest annual percentage gain for Healthequity's Free Cash Flow in the last 5 years was 59044.23% (2022), contrasted with its biggest fall of 14244.93% (2022).
  • Over the past 5 years, Healthequity's Free Cash Flow (Quarter) stood at $5.3 million in 2021, then skyrocketed by 590.44% to $36.8 million in 2022, then increased by 23.47% to $45.5 million in 2023, then skyrocketed by 71.42% to $78.0 million in 2024, then surged by 64.49% to $128.3 million in 2025.
  • Its Free Cash Flow was $128.3 million in Q4 2025, compared to $125.5 million in Q3 2025 and $48.7 million in Q2 2025.